Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study

OBJECTIVE: The purpose of this study was to investigate the efficacy and tolerability of atypical antipsychotics (AAPs) with augmentation by blonanserin in schizophrenic patients. METHODS: aA total of 100 patients with schizophrenia who were partially or completely unresponsive to treatment with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Young Sup, Park, Joo Eon, Kim, Do-Hoon, Sohn, Inki, Hwang, Tae-Yeon, Park, Young-Min, Jon, Duk-In, Jeong, Jong-Hyun, Bahk, Won-Myong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965658/
https://www.ncbi.nlm.nih.gov/pubmed/27482249
http://dx.doi.org/10.4306/pi.2016.13.4.458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965658/
https://www.ncbi.nlm.nih.gov/pubmed/27482249
http://dx.doi.org/10.4306/pi.2016.13.4.458

Ejemplares similares